Stay updated on Alvelestat in alpha1-antitrypsin COPD: Clinical Trial

Sign up to get notified when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Site version updated from v3.4.2 to v3.4.3; no visible changes to study details or page content.
    Difference
    0.0%
    Check dated 2026-03-07T07:48:27.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Only the site’s revision label was updated from v3.4.1 to v3.4.2; there are no visible changes to the page content or features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:11:21.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision numbers on the page were updated: added v3.4.1 and removed v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:40:12.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site updated from version v3.4.0 to v3.4.1; no visible changes to study details or layout are evident.
    Difference
    0.0%
    Check dated 2026-02-05T14:17:56.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Page footer revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T04:43:31.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Added a centralized Locations section listing study sites across the United States and Canada (Alabama, California, North Carolina, Alberta, British Columbia, Ontario, Saskatchewan) and removed the older per-location pages (e.g., Alabama Locations) and the HHS Vulnerability Disclosure link.
    Difference
    0.7%
    Check dated 2025-12-24T12:16:50.000Z thumbnail image

Stay in the know with updates to Alvelestat in alpha1-antitrypsin COPD: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvelestat in alpha1-antitrypsin COPD: Clinical Trial page.